The effect of glucocorticoid replacement therapy on bone mineral density in children with congenital adrenal hyperplasia

被引:10
|
作者
Cetinkaya, Semra [1 ]
Kara, Cengiz [1 ]
机构
[1] Childrens Hlth & Dis Training & Res Hosp, Ankara, Turkey
来源
关键词
bone mineral density; congenital adrenal hyperplasia; glucocorticoids; Turkish children; YOUNG-ADULT PATIENTS; 21-HYDROXYLASE DEFICIENCY; BODY-COMPOSITION; TURNOVER; MARKERS; WOMEN; GROWTH; GIRLS; BOYS; MASS;
D O I
10.1515/JPEM.2011.189
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: 1) To evaluate the effects of glucocorticoid (GC) doses on bone mineral density (BMD) in children with congenital adrenal hyperplasia (CAH), 2) Investigate other factors influencing BMD. Methods: Twenty-six children with CAH and 11 healthy controls included in the study. All of the patients were examined with dual-energy X-ray absorptiometry (DXA) using a Hologic QDR 1000/W densitometer. The metabolic control state, age at diagnosis GC dose (mg/m(2)/day), pubertal status, 17 hydroxyprogesterone (17 OHP) levels, bone age (BA), and lumber BMD were evaluated in all cases. BMD (g/cm(2)), BMD z-score corrected to National Standards (cNS-BMD z-score), BMD z-score corrected to BA (cBABMD), bone mineral content (BMC), BMC corrected to puberty (cPBMC), and bone area (BAR) values were determined. Patients were grouped according to mean on-therapy serum 17 OHP levels as tight control (17 OHP < 10 nmol/L) (n:13) and poor control (17 OHP > 10 nmol/L) (n: 13). All groups were compared with each other. Results: The age range was 2.1-15.7 years and the mean age (+/- SD) 9.3 (+/- 3.5) years. There were no significant differences between the groups in terms of GC doses, lumbar BMD values [ BMD (g/cm(2)), BMD z-score corrected to National Standards (cNS-BMD z-score), BMD z-score corrected to BA (cBABMD), bone mineral content (BMC), BMC corrected to puberty (cPBMC), and bone area (BAR)]. However, the BMI value was higher in children with CAH than normal healthy controls. The BA of the poor control, late diagnosed groups and male patients were higher than tight control, early diagnosed group and female patients, respectively. BMC and BA were lower than the control group in tight control with early diagnosed patients. The cBABMD z-score was lower in males with poor control than males with tight control. There were no similar results in female patients. Conclusions: Although GC treatment seems not to influence BMD in CAH patients in our study, further studies are needed to additionally evaluate daily calcium (Ca) intake, polymorphism of vitamin D receptor, ethnic factors (strict Islamic dress, etc.), socioeconomic status, and 24-h urinary free cortisol level.
引用
收藏
页码:265 / 269
页数:5
相关论文
共 50 条
  • [21] Effect of long-term glucocorticoid therapy on cardiac functions in children with congenital adrenal hyperplasia
    Amr, Nermine Hussein
    Mahmoud, Rana Abdelhakim Ahmed
    Youssef, Omneyia
    Toaima, Nadin Nabil
    Elsedfy, Heba
    CLINICAL ENDOCRINOLOGY, 2021, 94 (02) : 210 - 218
  • [22] Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia
    Falhammar, Henrik
    Nystrom, Helena Filipsson
    Wedell, Anna
    Brismar, Kerstin
    Thoren, Marja
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2013, 168 (03) : 331 - 341
  • [23] Long-term corticosteroid replacement and bone mineral density in adult women with classical congenital adrenal hyperplasia
    King, JA
    Wisniewski, AB
    Bankowski, BJ
    Carson, KA
    Zacur, HA
    Migeon, CJ
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (03): : 865 - 869
  • [24] Optimization of glucocorticoid replacement therapy: the long-term effect on bone mineral density
    Peacey, SR
    Guo, CY
    Eastell, R
    Weetman, AP
    CLINICAL ENDOCRINOLOGY, 1999, 50 (06) : 815 - 817
  • [25] Gonadotropin-Releasing Hormone Agonist Therapy and Longitudinal Bone Mineral Density in Congenital Adrenal Hyperplasia
    Flokas, Myrto Eleni
    Wakim, Paul
    Kollender, Sarah
    Sinaii, Ninet
    Merke, Deborah P.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (02): : 498 - 504
  • [26] Bone mineral density determinants in adolescents and young adults with congenital adrenal hyperplasia
    Navardauskaite, Ruta
    Vanckaviciene, Aurika
    Verkauskiene, Rasa
    FRONTIERS IN PEDIATRICS, 2024, 12
  • [27] Bone Mineral Density is Negatively Affected by Adiposity in Youth with Congenital Adrenal Hyperplasia
    Ryabets-Lienhard, Anna
    Nguyen, Justin
    Pickering, Trevor A.
    Fraga, Nicole
    Deras, Edwin A.
    Geffner, Mitchell E.
    Kim, Mimi S.
    HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 (SUPPL 3): : 53 - 54
  • [28] Timing and type of glucocorticoid replacement in adult congenital adrenal hyperplasia
    Ross, RJM
    Rostami-Hodjegan, A
    HORMONE RESEARCH, 2005, 64 : 67 - 70
  • [29] Bone mineral density, bone turnover markers, lean mass, and fat mass in Egyptian children with congenital adrenal hyperplasia
    El Dayem, Soha M. Abd
    Anwar, Ghada M.
    Salama, Hassan
    Kamel, Ashraf F.
    Emara, Nahed
    ARCHIVES OF MEDICAL SCIENCE, 2010, 6 (01) : 104 - 110
  • [30] Bone density in children with early classical congenital adrenal hyperplasia.
    Fleischman, A
    Ringelheim, J
    Feldman, HA
    Gordon, CM
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S180 - S180